The effect of E2 in preventing FAS-activation dependent apoptosis in breast cancer cells will have an impact on therapeutic response as active Fas/FasL can amplify the pro-apoptotic effects of chemotherapeutic drugs. The gene discussed is FAS; the disease is breast carcinoma.